Canada Pension Plan Investment Board raised its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 510.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 958,200 shares of the company's stock after buying an additional 801,200 shares during the period. Canada Pension Plan Investment Board owned about 0.39% of Oscar Health worth $12,878,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. JPMorgan Chase & Co. grew its position in Oscar Health by 348.7% during the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after acquiring an additional 8,051,379 shares during the last quarter. BIT Capital GmbH boosted its stake in shares of Oscar Health by 5,711.6% in the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock valued at $60,129,000 after purchasing an additional 4,396,872 shares in the last quarter. Hennessy Advisors Inc. grew its holdings in shares of Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after purchasing an additional 3,544,300 shares during the last quarter. Clearbridge Investments LLC purchased a new position in Oscar Health in the 4th quarter worth $19,088,000. Finally, American Century Companies Inc. raised its position in Oscar Health by 185.6% in the 4th quarter. American Century Companies Inc. now owns 1,285,204 shares of the company's stock worth $17,273,000 after purchasing an additional 835,144 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.
Oscar Health Trading Up 1.8 %
Shares of Oscar Health stock traded up $0.22 during trading on Friday, reaching $12.25. 3,438,416 shares of the stock were exchanged, compared to its average volume of 3,888,266. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The firm has a market cap of $3.07 billion, a price-to-earnings ratio of -612.19 and a beta of 1.75. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock's fifty day moving average is $13.63 and its 200 day moving average is $14.88.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price objective for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $20.21.
Read Our Latest Stock Report on OSCR
Oscar Health Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.